In addition to WT, HACE1 inactivation has been reported in multiple other tumor types, including non-Hodgkin’s lymphoma, as well as lung, ovarian, pancreatic, and prostate carcinomas [1, 3–14]. Here, HACE1 is linked to neoplasm.